Developed as an SNRI antidepressant,_____ has been approved by the FDA to treat ADHD in children,adolescents,and adults.

Question

Quizplus · Accepted Answer

Atomoxetine, commonly known as Strattera, has been approved by the FDA to treat ADHD in children, adolescents, and adults. While it was originally developed as an SNRI antidepressant, it has been found to be effective in treating ADHD symptoms. Reboxetine (A) is a selective norepinephrine reuptake inhibitor (NRI) used as an antidepressant in some countries, but it has not been approved for ADHD treatment. Imipramine (B) is a tricyclic antidepressant that has also been used to treat bedwetting and some anxiety disorders, but is not an approved ADHD medication. Bupropion (D), though a norepinephrine-dopamine reuptake inhibitor (NDRI), is not commonly used for ADHD treatment and is more commonly prescribed as an antidepressant or smoking cessation aid.

Developed as an SNRI Antidepressant,_____ Has Been Approved by the FDA